Merck and Co. SWOT and PESTLE Analysis

Merck & Co., Inc., headquartered in Kenilworth, New Jersey, is an American global pharmaceutical business. Merck & Co. has its roots in Merck Group, a former German parent firm founded by the Merck family in 1668 when Friedrich Jacob Merck bought a medicine business in Darmstadt. Merck & Co. was founded in 1891 as a subsidiary of Merck & Co. in the United States. The company remains at the forefront of research to prevent and treat diseases that threaten people and animals, such as cancer, infectious diseases like HIV and Ebola, and emerging animal diseases. The company works with clients and operates in more than 140 countries to supply innovative health solutions through prescription medications, vaccines, biological therapies, and animal health products. It also shows its dedication to expanding access to health care by implementing far-reaching policies, programmes, and collaborations. Merck announced in June 2022 that the FDA had approved an expanded indication for VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine) (pronounced VAKS-noo-vans) to include children aged 6 weeks to 17 years.

Merck & Co.'s Unique Selling Point or USP lies in it being the world's leading biopharmaceutical firm, with more than a century of experience creating for life and developing medicines and vaccines for some of the world's most difficult diseases. The mission statement of Merck & Co. reads, "We aspire to improve the health and wellness of people and animals worldwide and to expand access to our medicines and vaccines. All of our actions must be measured against our responsibility to those who use or need our products".